Literature DB >> 8251592

Macrophage-Cryptococcus interactions.

S M Levitz1.   

Abstract

Macrophages are a heterogeneous population that vary depending on their species of origin, anatomic location, state of activation, and conditions of culture. Moreover, macrophages normally interact with other cells both within and without the immune system. It is clear from the data reviewed in this chapter that all of these aforementioned variables greatly influence macrophage-C. neoformans interactions. While circumstantial evidence strongly supports a major role for the macrophage in host defenses against cryptococcosis, the nature and extent of the contribution macrophages make remain to be defined. One major challenge for researchers in this field will be to design experiments that closely mimic what occurs in human physiological and pathological states.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8251592

Source DB:  PubMed          Journal:  Immunol Ser        ISSN: 0092-6019


  23 in total

1.  Cryptococcus neoformans variants generated by phenotypic switching differ in virulence through effects on macrophage activation.

Authors:  A Guerrero; N Jain; X Wang; B C Fries
Journal:  Infect Immun       Date:  2010-01-04       Impact factor: 3.441

2.  Role of dendritic cells and alveolar macrophages in regulating early host defense against pulmonary infection with Cryptococcus neoformans.

Authors:  John J Osterholzer; Jami E Milam; Gwo-Hsiao Chen; Galen B Toews; Gary B Huffnagle; Michal A Olszewski
Journal:  Infect Immun       Date:  2009-06-29       Impact factor: 3.441

3.  Binding of Cryptococcus neoformans to heterologously expressed human complement receptors.

Authors:  S M Levitz; A Tabuni; T R Kozel; R S MacGill; R R Ingalls; D T Golenbock
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

4.  Variables affecting production of monocyte chemotactic factor 1 from human leukocytes stimulated with Cryptococcus neoformans.

Authors:  S M Levitz; E A North; Y Jiang; S H Nong; H Kornfeld; T S Harrison
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

5.  Chloroquine induces human mononuclear phagocytes to inhibit and kill Cryptococcus neoformans by a mechanism independent of iron deprivation.

Authors:  S M Levitz; T S Harrison; A Tabuni; X Liu
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

6.  Mechanisms of inhibition of Cryptococcus neoformans by human lymphocytes.

Authors:  S M Levitz; E A North; M P Dupont; T S Harrison
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

7.  Effects of interleukin-10 on human peripheral blood mononuclear cell responses to Cryptococcus neoformans, Candida albicans, and lipopolysaccharide.

Authors:  S M Levitz; A Tabuni; S H Nong; D T Golenbock
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

8.  Enhanced innate immune responsiveness to pulmonary Cryptococcus neoformans infection is associated with resistance to progressive infection.

Authors:  Loïc Guillot; Scott F Carroll; Robert Homer; Salman T Qureshi
Journal:  Infect Immun       Date:  2008-08-04       Impact factor: 3.441

9.  Production of tumor necrosis factor alpha in human leukocytes stimulated by Cryptococcus neoformans.

Authors:  S M Levitz; A Tabuni; H Kornfeld; C C Reardon; D T Golenbock
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

10.  Differential activation of peritoneal cells by subcutaneous treatment of rats with cryptococcal antigens.

Authors:  José L Baronetti; Laura S Chiapello; Ana P Garro; Diana T Masih
Journal:  Clin Vaccine Immunol       Date:  2009-06-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.